58 related articles for article (PubMed ID: 25359303)
1. Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables.
Wang C; Civan J; Lai Y; Cristofanilli M; Hyslop T; Palazzo JP; Myers RE; Li B; Ye Z; Zhang K; Xing J; Yang H
Cancer Causes Control; 2015 Jan; 26(1):45-56. PubMed ID: 25359303
[TBL] [Abstract][Full Text] [Related]
2. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
3. Characteristics associated with differences in survival among black and white women with breast cancer.
Silber JH; Rosenbaum PR; Clark AS; Giantonio BJ; Ross RN; Teng Y; Wang M; Niknam BA; Ludwig JM; Wang W; Even-Shoshan O; Fox KR
JAMA; 2013 Jul; 310(4):389-97. PubMed ID: 23917289
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study.
O'Malley CD; Le GM; Glaser SL; Shema SJ; West DW
Cancer; 2003 Mar; 97(5):1303-11. PubMed ID: 12599239
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in adjuvant systemic therapy for early breast cancer among Medicaid beneficiaries.
Balasubramanian BA; Demissie K; Crabtree BF; Ohman Strickland PA; Kohler B; Rhoads GG
Breast J; 2010; 16(2):162-8. PubMed ID: 20030647
[TBL] [Abstract][Full Text] [Related]
7. Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.
Farias AJ; Du XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1266-1275. PubMed ID: 28515111
[No Abstract] [Full Text] [Related]
8. Racial differences in outcomes for patients with metastatic breast cancer by disease subtype.
Vaz-Luis I; Lin NU; Keating NL; Barry WT; Lii H; Winer EP; Freedman RA
Breast Cancer Res Treat; 2015 Jun; 151(3):697-707. PubMed ID: 26022349
[TBL] [Abstract][Full Text] [Related]
9. Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.
Lai Y; Palazzo JP; Cristofanilli M; Hyslop T; Civan J; Avery T; Myers RE; Li B; Ye Z; Xing J; Yang H
Breast Cancer Res Treat; 2014 Nov; 148(1):175-85. PubMed ID: 25261294
[TBL] [Abstract][Full Text] [Related]
10. Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer.
Williams CD; Salama JK; Moghanaki D; Karas TZ; Kelley MJ
J Thorac Oncol; 2016 Oct; 11(10):1672-81. PubMed ID: 27296104
[TBL] [Abstract][Full Text] [Related]
11. Disparities in survival after female breast cancer diagnosis: a population-based study.
Tannenbaum SL; Koru-Sengul T; Miao F; Byrne MM
Cancer Causes Control; 2013 Sep; 24(9):1705-15. PubMed ID: 23775026
[TBL] [Abstract][Full Text] [Related]
12. Racial Disparity Among Women Diagnosed With Invasive Breast Cancer in a Large Integrated Health System.
Singh M; Konduri SD; Bobustuc GC; Kassam AB; Rovin RA
J Patient Cent Res Rev; 2018; 5(3):218-228. PubMed ID: 31414006
[TBL] [Abstract][Full Text] [Related]
13. Multiple mediation analysis of racial disparity in breast cancer survival.
Hines RB; Zhu X; Lee E; Rapp CD; Volk AM; Johnson AM
Cancer Epidemiol; 2022 Aug; 79():102206. PubMed ID: 35759875
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy: a major factor in the five-year survival analysis of women with breast cancer in Lagos, Nigeria.
Makanjuola SB; Popoola AO; Oludara MA
Radiother Oncol; 2014 May; 111(2):321-6. PubMed ID: 24746579
[TBL] [Abstract][Full Text] [Related]
15. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
[TBL] [Abstract][Full Text] [Related]
17. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
Li CI; Malone KE; Daling JR
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
[TBL] [Abstract][Full Text] [Related]
18. Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population.
Ru Y; Liu J; Fantacone-Campbell JL; Zhu K; Kovatich AJ; Hooke JA; Kvecher L; Deyarmin B; Kovatich AW; Cammarata F; Hueman MT; Rui H; Mural RJ; Shriver CD; Hu H
Mil Med; 2017 Nov; 182(11):e1851-e1858. PubMed ID: 29087852
[TBL] [Abstract][Full Text] [Related]
19. Advanced Stage at Presentation Remains a Major Factor Contributing to Breast Cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country.
Kong YC; Bhoo-Pathy N; Subramaniam S; Bhoo-Pathy N; Taib NA; Jamaris S; Kaur K; See MH; Ho GF; Yip CH
Int J Environ Res Public Health; 2017 Apr; 14(4):. PubMed ID: 28420149
[No Abstract] [Full Text] [Related]
20. Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study.
Dong J; Garacci Z; Buradagunta CS; D'Souza A; Mohan M; Cunningham A; Janz S; Dhakal B; Thrift AP; Hari P
Blood Cancer J; 2022 Feb; 12(2):34. PubMed ID: 35210395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
